The prior authorization requirements when diabetes is present If you have type 2 diabetes and want MassHealth to cover a GLP-1 medication (Ozempic, not Wegovy), the prior authorization pathway requires: Clinical criteria: Documented type 2 diabetes diagnosis (ICD-10 code E11.x) BMI of 27 or higher At least one obesity-related comorbidity: hypertension, dyslipidemia, cardiovascular disease, or sleep apnea HbA1c of 7.0% or higher despite current therapy Trial and inadequate response to metformin for at least 90 days (documented by prescription fill history or provider attestation) Trial and inadequate response to at least one additional oral diabetes medication (sulfonylurea, DPP-4 inhibitor, or SGLT2 inhibitor) for at least 90 days Documentation requirements: Current HbA1c lab result (within 90 days) Current weight and BMI List of prior diabetes medications with dates and reasons for discontinuation or inadequacy Treatment plan including diet and exercise counseling The prior authorization is reviewed by MassHealth's pharmacy benefit manager (currently Gainwell Technologies as of 2026)
Both kidneys were also meticulously dissected, and the right kidney was preserved in 10% formalin solution for histopathological and immunohistochemical examinations
however, given the cross-sectional design and modest sample size, this interpretation remains tentative
Sure, veterans can develop diabetes, but a peptide wasnt an artificial limb, something that could immediately benefit a retired soldier
The dosing chart below outlines the available microdose levels for treatment and the typical next step if your doctor decides to adjust your dose every two weeks
:max_bytes(150000):strip_icc():focal(742x202:744x204)/GLP1-Now-Affordable-052926-1d50af52042b44b79fc71edef280243d.jpg)
